Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 27, 2023

Efficacy of PD-L1 Blockade in Combination With Carboplatin as Immune Induction in Patients With Metastatic Lobular Breast Cancer

Nature Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

Nature Cancer
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
Nat Cancer 2023 Apr 01;4(4)535-549, L Voorwerk, OI Isaeva, HM Horlings, S Balduzzi, M Chelushkin, NAM Bakker, E Champanhet, H Garner, K Sikorska, CE Loo, I Kemper, IAM Mandjes, M de Maaker, JJL van Geel, J Boers, M de Boer, R Salgado, MGJ van Dongen, GS Sonke, KE de Visser, TN Schumacher, CU Blank, LFA Wessels, A Jager, VCG Tjan-Heijnen, CP Schröder, SC Linn, M Kok

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading